updated 4/19/2011 4:16:56 PM ET 2011-04-19T20:16:56

ORLANDO, Fla., April 19, 2011 (GLOBE NEWSWIRE) -- RedChip Research™, a division of RedChip Companies, Inc., today announced it has issued a research update on Aethlon Medical, Inc. (OTCBB:AEMD), a company developing therapeutic filtration devices to address infectious disease and cancer.

To receive a complimentary copy of the RedChip Research Report for AEMD, please visit: http://www.redchip.com/about/aboutmain.asp?rid=357

To learn more about Aethlon Medical, Inc. visit http://www.redchip.com/visibility/investor.asp?symbol=AEMD

About RedChip Companies, Inc.

RedChip Companies is an international, small-cap research and financial public relations firm headquartered in Orlando, Florida; with affiliate offices in Beijing, China; Paris, France; and Seoul, Korea. RedChip delivers concrete, measurable results for its clients through its extensive national and international network of small-cap institutional and retail investors. RedChip has developed the most comprehensive platform of products and services for small-cap companies, including: RedChip Research™, Traditional Investor Relations, Digital Investor Relations, Institutional and Retail Conferences, RedChip Small-Cap TV™, Shareholder Intelligence, Social Media and Blogging Services, Webcasts, and RedChip Radio™. To learn more about RedChip's products and services please visit: http://www.redchip.com/visibility/productsandservices.asp .

"Discovering Tomorrow's Blue Chips Today"™

The RedChip Companies, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=2761

Disclosure

None of the reports issued by RedChip Companies, Inc., constitutes a recommendation for any investor to purchase or sell any particular security nor do they constitute investment advice. RedChip certifies that no part of the analysts' compensation was, is, or will be, directly or indirectly, related to the specific recommendation or views expressed by the analyst in the report. Information contained in the research reports is obtained from sources believed to be reliable, but its accuracy and completeness are not guaranteed. Aethlon Medical, Inc. (AEMD) is a client of RedChip Companies, Inc. and of RedChip Visibility, a division of RedChip Companies. AEMD has agreed to pay RedChip Companies, Inc. a fee of 250,000 shares of Rule 144 stock for twelve (12) months of RedChip Visibility Program and six (6) months of investor awareness services. RedChip Visibility Program services include the preparation of the equity research report(s). The equity research report(s) are prepared for informational purposes only and are paid for by the company portrayed in the report. The equity research report(s) are not a recommendation of a solicitation to purchase or sell any security, nor do they constitute investment advice. Investor awareness services and programs are designed to help companies communicate their investment characteristics. These services may include investor conferences, digital and print distribution of AEMD investor-related materials or services, and radio programming. None of the profiles issued by RedChip Companies, Inc., constitutes a recommendation for any investor to purchase or sell any particular security or that any security is suitable for any investor. Any investor should determine whether a particular security is suitable based on the investor's objectives, other securities holdings, financial situation needs, and tax status. All materials are subject to change without notice. Information is obtained from sources believed to be reliable, but its accuracy and completeness are not guaranteed. RedChip Companies, Inc., employees and affiliates may have positions and affect transactions in the securities or options of the issuers mentioned herein.

CONTACT: RedChip Companies Inc.
         1-800-REDCHIP (733-2447)
         research@redchip.com
         http://www.redchip.com

© Copyright 2012, GlobeNewswire, Inc. All Rights Reserved

Discuss:

Discussion comments

,

Most active discussions

  1. votes comments
  2. votes comments
  3. votes comments
  4. votes comments

Data: Latest rates in the US

Home equity rates View rates in your area
Home equity type Today +/- Chart
$30K HELOC FICO 4.97%
$30K home equity loan FICO 5.23%
$75K home equity loan FICO 4.67%
Credit card rates View more rates
Card type Today +/- Last Week
Low Interest Cards 13.28%
13.21%
Cash Back Cards 17.74%
17.70%
Rewards Cards 17.01%
16.96%
Source: Bankrate.com